Injeq Oy has attracted more than €1.65 million from over 700 investors through its equity crowdfunding campaign on Invesdor. The company launched the initiative in order to bring its smart Injeq IQ-Needle to the European medical device market.
The tissue identification functionality of Injeq IQ-Needle is described as introducing a new standard level for both security and success, because it immediately alerts as the needle tip reaches its target; the spinal fluid. The smart needle products have been used in clinical patient trials and the positive performance has been reported in the Journal of Clinical Monitoring and Computing. A lumbar puncture study with pediatric patients started in 2016 and is today proceeding at two university hospitals in Finland.
The new funding will allow the company to keep pace and to expand clinical studies to leading hospitals in Sweden, Norway and Denmark during the fall of 2017. Commercial deliveries are expected to take place during the first half of 2018.
The news was first published by Crowdfund Insider. Read the whole story
More information on the crowdfunding campaign: https://www.invesdor.com/en/pitches/833